Business Context and Reporting Period
This Form 8-K, dated May 5, 2025, reports on NextTrip, Inc. (NTRP), a Nevada corporation. The filing details the completion of a reverse acquisition of NextTrip Holdings, Inc. that closed on December 29, 2023. The report specifically addresses the final issuance of contingent shares tied to the achievement of business milestones under the original Share Exchange Agreement.
Key Financial Metrics and Capital Structure
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial metric disclosed is the issuance of equity securities:
- Shares Issued: 1,450,000 Contingent Shares of Common Stock.
- Recipient: NextTrip Sellers (NextTrip Parent's members).
- Transaction Type: Unregistered sale of equity securities exempt under Section 4(a)(2) of the Securities Act and Regulation D.
- Remaining Obligations: Zero. All contingent shares issuable under the Exchange Agreement have now been issued.
Material Changes Versus Prior Period
The material change reported is the satisfaction of the fourth and final milestone event under the Exchange Agreement. This issuance follows a previous distribution of 4,393,993 Contingent Shares on March 26, 2025, which satisfied the first three milestones. The May 5, 2025 issuance marks the conclusion of the equity issuance obligations related to the acquisition.
Outlook, Risks, and Management Commentary
Management Commentary: The Company confirms that the issuance of the final 1,450,000 shares fulfills all obligations under the Exchange Agreement. No further shares are committed to be issued pursuant to this agreement.
Risks and Contingencies:
- Regulatory Compliance: The issuance was contingent upon Nasdaq's approval of the Company's initial listing application, which was received on March 25, 2025. Without this approval, the issuance could have triggered delisting proceedings.
- Restricted Securities: The issued shares are "restricted securities" under Rule 144 and were issued to accredited investors.
Investor Verification Checklist
- Verify the total number of outstanding shares post-issuance to assess dilution impact.
- Confirm the current status of the Nasdaq initial listing application and trading status of NTRP.
- Review the specific criteria for the fourth milestone (Commercial launch of PayDelay technology in the NXT2.0 system) to validate the achievement claim.
- Check for any subsequent filings regarding the vesting or transfer restrictions on the newly issued 1,450,000 shares.